Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific Embol-X Buy Readies Firm For Carotid Stent Race

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific's acquisition of embolic protection technology developed by Embol-X may help level the playing field with competitors Guidant and Johnson & Johnson in the race to bring carotid stent technology to market.

You may also be interested in...



Edwards Enters Embolic Filtration Market With Embol-X Technology

Edwards Lifesciences will offer embolic filtration technology developed by Embol-X, Inc. for use during open-heart procedures such as valve replacement under an asset purchase valued at about $10 mil

Edwards Enters Embolic Filtration Market With Embol-X Technology

Edwards Lifesciences will offer embolic filtration technology developed by Embol-X, Inc. for use during open-heart procedures such as valve replacement under an asset purchase valued at about $10 mil

Boston Scientific Gains Distal Protection Market Entry With EPI's Filterwire

Boston Scientific's $75 mil. acquisition of Embolic Protection, Inc. provides an immediate entry into the vascular distal protection market.

Related Content

UsernamePublicRestriction

Register

ID1122310

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel